MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

InflaRx N.V. - Common Stock (NQ:IFRX)

2.120 +0.010 (+0.47%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,226,851
Open 2.130
Bid (Size) 2.110 (7,700)
Ask (Size) 2.120 (4,300)
Prev. Close 2.110
Today's Range 2.041 - 2.330
52wk Range 0.7406 - 2.949
Shares Outstanding 44,203,763
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos
From InflaRx N.V.
Via GlobeNewswire
News headline image
InflaRx Investor Update: Izicopan Set to Take Center Stage in AAV and Renal Disease Pipeline ↗
InflaRx (NASDAQ:IFRX) outlined plans to prioritize development of izicopan, an oral inhibitor of the C5a receptor (C5aR), in ANCA-associated vasculitis (AAV) and other renal diseases during a company... 
Via MarketBeat

Performance

YTD
+94.5%
+94.5%
1 Month
+24.0%
+24.0%
3 Month
+124.7%
+124.7%
6 Month
+86.0%
+86.0%
1 Year
+158.5%
+158.5%

More News

Read More
News headline image
InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares
From InflaRx N.V.
Via GlobeNewswire
News headline image
InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares
From InflaRx N.V.
Via GlobeNewswire
IFRX Stock Soars Pre-Market After Experimental Drug Shows Promise In Treating Chronic Skin Diseases ↗
Via Stocktwits
News headline image
InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases
From InflaRx N.V.
Via GlobeNewswire
Friday's session: top gainers and losers ↗
Via Chartmill
News headline image
Get insights into the top gainers and losers of Friday's after-hours session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Is InflaRx NV Gaining or Losing Market Support? ↗
Via Benzinga
News headline image
These stocks have an unusual volume in today's session ↗
Via Chartmill
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
News headline image
Earnings Season: Synergy CHC (NASDAQ: SNYR) FOCUSfactor® Beverage – Eyes $100M+ in 2026 – More Stocks Reporting Inside
Via AB Newswire
Topics Artificial Intelligence
News headline image
Top movers analysis one hour before the close of the markets on 2025-11-10: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
These stocks are the most active in today's session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Viasat Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
What's going on in today's after hours session ↗
Via Chartmill
News headline image
Biogen's Immunology Pipeline Has Long-Term Potential: Analyst ↗
Via Benzinga
News headline image
Top 4 Biotech Stocks Set For A Breakout: Momentum Scores Surge ↗
Via Benzinga
News headline image
Top movers analysis one hour before the close of the markets on 2025-08-29: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga

Frequently Asked Questions

Is InflaRx N.V. - Common Stock publicly traded?
Yes, InflaRx N.V. - Common Stock is publicly traded.
What exchange does InflaRx N.V. - Common Stock trade on?
InflaRx N.V. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for InflaRx N.V. - Common Stock?
The ticker symbol for InflaRx N.V. - Common Stock is IFRX on the Nasdaq Stock Market
What is the current price of InflaRx N.V. - Common Stock?
The current price of InflaRx N.V. - Common Stock is 2.120
When was InflaRx N.V. - Common Stock last traded?
The last trade of InflaRx N.V. - Common Stock was at 07/07/26 04:00 PM ET
What is the market capitalization of InflaRx N.V. - Common Stock?
The market capitalization of InflaRx N.V. - Common Stock is 93.71M
How many shares of InflaRx N.V. - Common Stock are outstanding?
InflaRx N.V. - Common Stock has 94M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story